Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: June 15, 2026
Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2025
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
A prospective clinical trial of GVHD prophylaxis with posttransplant cyclophosphamide and abatacept.
Journal: Blood advances
Published: October 17, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 16, 2024
Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies.
Journal: Leukemia & lymphoma
Published: January 23, 2024
IDH2-mutated near ETP-ALL with aggressive leukemia cutis and brisk response to venetoclax and decitabine.
Journal: Leukemia research reports
Published: May 24, 2023
Myeloid lineage switch following CD7-targeted chimeric antigen receptor T-cell therapy in relapsed/refractory T-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: May 22, 2023
Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 08, 2023
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Journal: Transplantation and cellular therapy
Published: June 27, 2022
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.
Journal: Leukemia & lymphoma
Published: February 21, 2022
Last Updated: 09/26/2026